Condition
Sarcopenia in Elderly clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Sarcopenia in Elderly clinical trials that are recruiting, at sites in 13 countries (most in South Korea (3), United States (3), Taiwan (2)). By phase: Phase 2 (3), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 13Countries
Newest Sarcopenia in Elderly clinical trials
All recruiting trials (18)
-
Egg white pudding supplement in care homes for sarcopenia in older adults
This study tests whether daily egg white pudding can help residents in personal care homes who receive dietary supplements and have sarcopenia, compared with a standard supplement.
-
Impact of pre-operative sarcopenia on recovery after hip replacement in older adults
This study tests whether low muscle mass and strength before hip replacement affect recovery in people 75 and older who have hip fracture or severe osteoarthritis.
-
Predicting function and quality-of-life decline after curative surgery for gastrointestinal cancer in people over 65
This project will try to see which pre- and perioperative factors predict loss of independence and worse quality of life over one year in people aged 65 and older who have curative surgery for gastrointestinal cancers.
-
PLH-2301 for sarcopenia in older adults
This study will try whether taking PLH-2301 once daily for 12 weeks improves physical function in people aged 65 and older with sarcopenia compared with a placebo.
-
Movement and nutrition plan to prevent loss of function in older hospital patients
The study tests whether a supervised, personalized exercise program plus nutrition guidance can prevent declines in daily function for patients 65 and older during a hospital stay.
-
Volunteer-led lifestyle program to help sarcopenia in older adults
This program tests a digital, volunteer-supported lifestyle plan to improve muscle health and reduce fall risk in older adults with sarcopenia or frailty.
-
MediDrink Platinum+ with a new fava bean protein and optional PeptiStrong to improve fitness in older adults with sarcopenia
This trial will see if MediDrink Platinum+ with a novel protein blend, given alone or together with PeptiStrong, improves fitness in malnourished adults aged 60 and older who have sarcopenia.
-
Blood Flow Restriction Training for older adults in acute rehabilitation
This trial tests whether blood flow restriction training on a stationary bike can help improve muscle mass and general health in people over 65 during two weeks of acute geriatric rehabilitation after hip-related injury.
-
Linking swallowing problems to suprahyoid muscle activity in sarcopenic dysphagia
This project tests whether older adults with sarcopenia who have swallowing difficulty show altered suprahyoid muscle activity on surface EMG that corresponds to phase-specific problems seen on videofluoroscopy.
-
AMC6156 for older adults with sarcopenia
This trial will try once-daily AMC6156 pills or a placebo for 12 weeks to see if they improve strength and mobility in older adults with sarcopenia.
-
Effects of leucine and fatty acids on muscle health in older adults
This study is testing if adding leucine-rich protein and healthy fats to the diets of older adults can help improve their muscle health and strength.
-
Evaluating JUICE HA® for improving muscle health in older adults with sarcopenia
This study is testing whether a new supplement called JUICE HA® can help older adults with muscle loss feel stronger and improve their quality of life.
-
Micronized creatine to help muscle strength and performance after knee replacement in older adults
This trial will test whether taking daily creatine for 12 weeks after knee replacement helps people 65 and older keep muscle, regain strength, and recover function.
-
Movement-speed biofeedback to improve muscle activation and self-perception in older adults with sarcopenia
This test will see if giving older adults with sarcopenia feedback on how fast they move during leg-press exercises helps preserve movement speed, increase muscle activation, and change motivation and perceived effort.
-
Eccentric exercise program for older adults with heart failure and muscle loss
This study is testing a 12-week exercise program for older adults with heart failure and muscle loss to see if it can help them get stronger and feel better.
-
Tirzepatide effects on muscle and blood-vessel health in older adults with obesity
This trial will try tirzepatide for six months in adults 50 and older with obesity but without diabetes to see if it changes muscle mass, strength, and blood vessel health.
-
Using denosumab to treat sarcopenia in elderly patients with osteoporosis
This study is testing if denosumab can help older adults with osteoporosis build muscle strength and improve their overall health.
-
Investigating protein changes in aging and muscle function
This study is trying to see how changes in muscle proteins affect strength and movement in older adults to help improve their recovery and mobility.
Related topics
Quick answers
How many Sarcopenia in Elderly clinical trials are recruiting right now?
18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in South Korea (3 trials), United States (3 trials), Taiwan (2 trials), Germany (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.